FILING ANALYSIS · TUESDAY, NOVEMBER 10
SANUWAVE Health, Inc. SNWV — 8-K: Results of Operations and Financial Condition
negative
Sanuwave Health reported a 24% decrease in Q3 revenues to $8.6 million and a GAAP operating loss of $1.1 million, citing the impact of the CMS proposed rule on skin substitute pricing and 97610 code changes, which affected system sales and customer operations. The company's cash and cash equivalents were $6.6 million as of September 30, 2026.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →